Cooper Companies (COO) Financial Analysis & Valuation | Quarter Chart
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and tor... more
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets cont... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $10.60B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Albert G. White |
| IPO Date | 1983-01-21 | CAGR | 6.49% |
| Employees | 15,000 | Website | www.coopercos.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.23% | Total Yield | 0.23% |
COO chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $16.60B | P/E | 11.92 | Forward P/E | 11.34 | PEG | 0.42 |
| P/S | 5.53 | P/B | 2.76 | P/CF | 127.2 | P/FCF | 258.21 |
| Sales | $4.24B | Sales 1Y | 4.73% | Sales 3Y | 20.57% | Sales 5Y | 48.93% |
| EPS | $4.56 | EPS 1Y | 44.33% | EPS 3Y | 110.79% | EPS 5Y | -95.01% |
| Sales QoQ | -1.41% | EPS QoQ | -660% | Sales QoQ Avg | 0.2% | EPS QoQ Avg | -194.84% |
| Gross Margin | 63.64% | Operating Margin | 12.85% | Profit Margin | 13.46% | ROCE | 5.04% |
| ROA | 4% | ROE | 7% | Altman Z Score | 2.9 | Piotroski Score | 6 |
| Current Ratio | 1.22 | Quick Ratio | 0.73 | Cash Ratio | 0.08 | Op. CF Ratio | -0.27 |
| Debt/Equity | 0.31 | Debt/Assets | 0.2 | Lt Debt/Equity | 0.23 | Lt Debt/Cap. | 0.19 |
| Intrst Cov. | 5.76 | Inventory Turnover | 1.69 | Asset Turnover | 0.33 | Receivables Turnover | 5.37 |
| Enterprise Value | $16.60B | P/E Ratio | 11.92 |
| Forward P/E | 11.34 | PEG Ratio | 0.42 |
| P/S Ratio | 5.53 | P/B Ratio | 2.76 |
| P/CF Ratio | 127.2 | P/FCF Ratio | 258.21 |
| EPS | $4.56 | EPS Growth 1Y | 44.33% |
| EPS Growth 3Y | 110.79% | EPS Growth 5Y | -95.01% |
| Revenue Growth 1Y | 4.73% | Gross Margin | 63.64% |
| Operating Margin | 12.85% | Profit Margin | 13.46% |
| ROE | 7% | ROA | 4% |
| ROCE | 5.04% | Current Ratio | 1.22 |
| Quick Ratio | 0.73 | Cash Ratio | 0.08 |
| Debt/Equity | 0.31 | Interest Coverage | 5.76 |
| Altman Z Score | 2.9 | Piotroski Score | 6 |
Cooper Companies (COO) valuation & financials
Cooper Companies (COO) has a market capitalization of $10.60B and trades at a price-to-earnings ratio of 11.9. It operates in the Healthcare sector (Medical - Instruments & Supplies).
Cooper Companies's revenue grew +4.7% over the last year.
Cooper Companies's next earnings report is scheduled for December 3, 2026 after market close (provider scheduled date); analysts estimate EPS of $1.07. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)